Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer

  • Technology appraisal guidance
  • TA192
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

February 2014: Implementation section updated to clarify that gefitinib is recommended as an option for treating locally advanced or metastatic non-small-cell lung cancer.

ISBN: 978-1-4731-6523-6